Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression
Author(s) -
Kol Jia Yong,
Daniela S. Daniela Sanchez Bassères,
Robert S. Welner,
Wen Cai Zhang,
Henry Yang,
Benedict Yan,
Meritxell Alberich-Jordà,
Junyan Zhang,
Lorena Lôbo Figueiredo-Pontes,
Chiara Battelli,
Christopher J. Hetherington,
Min Ye,
Hong Zhang,
Giorgia Maroni,
Karen O’Brien,
Maria Cristina Magli,
Alain Borczuk,
Lyuba Varticovski,
Olivier Kocher,
Pu Zhang,
Young-Choon Moon,
Nadiya Sydorenko,
Liangxian Cao,
Thomas W. Davis,
Bhavin Thakkar,
Ross A. Soo,
Atsushi Iwama,
Bing Lim,
Balázs Halmos,
Doneuberg,
Daniel G. Tenen,
Elena Levantini
Publication year - 2016
Publication title -
science translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.819
H-Index - 216
eISSN - 1946-6242
pISSN - 1946-6234
DOI - 10.1126/scitranslmed.aad6066
Subject(s) - bmi1 , cancer research , lung , medicine , adenocarcinoma , lung cancer , oncology , biology , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom